257 related articles for article (PubMed ID: 25374674)
21. Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Malard F; Labopin M; Stuhler G; Bittenbring J; Ganser A; Tischer J; Michallet M; Kröger N; Schmid C; Huynh A; Hallek M; Savani BN; Mohty M; Nagler A
Biol Blood Marrow Transplant; 2017 Feb; 23(2):278-284. PubMed ID: 27816650
[TBL] [Abstract][Full Text] [Related]
22. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment.
Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815
[TBL] [Abstract][Full Text] [Related]
23. Leukemia Stem Cell Release From the Stem Cell Niche to Treat Acute Myeloid Leukemia.
Villatoro A; Konieczny J; Cuminetti V; Arranz L
Front Cell Dev Biol; 2020; 8():607. PubMed ID: 32754595
[TBL] [Abstract][Full Text] [Related]
24. Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy.
Elgarten CW; Aplenc R
Curr Opin Pediatr; 2020 Feb; 32(1):57-66. PubMed ID: 31815781
[TBL] [Abstract][Full Text] [Related]
25. Novel therapeutic options in Acute Myeloid Leukemia.
Medinger M; Lengerke C; Passweg J
Leuk Res Rep; 2016; 6():39-49. PubMed ID: 27752467
[TBL] [Abstract][Full Text] [Related]
26. FLAMSA-Based Reduced-Intensity Conditioning versus Myeloablative Conditioning in Younger Patients with Relapsed/Refractory Acute Myeloid Leukemia with Active Disease at the Time of Allogeneic Stem Cell Transplantation: An Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Rodríguez-Arbolí E; Labopin M; Tischer J; Brecht A; Ganser A; Finke J; Blau IW; Kröger N; Kalhs P; Forcade E; Bunjes D; Spyridonidis A; Savani B; Nagler A; Mohty M
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2165-2173. PubMed ID: 32717436
[TBL] [Abstract][Full Text] [Related]
27. Acute Myeloid Leukemia and the Bone Marrow Niche-Take a Closer Look.
Behrmann L; Wellbrock J; Fiedler W
Front Oncol; 2018; 8():444. PubMed ID: 30370251
[TBL] [Abstract][Full Text] [Related]
28. Acute myeloid leukemia-induced remodeling of the human bone marrow niche predicts clinical outcome.
Chen Y; Hoffmeister LM; Zaun Y; Arnold L; Schmid KW; Giebel B; Klein-Hitpass L; Hanenberg H; Squire A; Reinhardt HC; Dührsen U; Bertram S; Hanoun M
Blood Adv; 2020 Oct; 4(20):5257-5268. PubMed ID: 33108453
[TBL] [Abstract][Full Text] [Related]
29. Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions.
Kanate AS; Pasquini MC; Hari PN; Hamadani M
World J Stem Cells; 2014 Apr; 6(2):69-81. PubMed ID: 24772235
[TBL] [Abstract][Full Text] [Related]
30. Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center.
Ciurea SO; Labopin M; Socie G; Volin L; Passweg J; Chevallier P; Beelen D; Milpied N; Blaise D; Cornelissen JJ; Fegueux N; Polge E; Kongtim P; Rondon G; Esteve J; Mohty M; Savani BN; Champlin RE; Nagler A
Cancer; 2018 May; 124(10):2134-2141. PubMed ID: 29469961
[TBL] [Abstract][Full Text] [Related]
31. [Effect of NCCN (2015) risk stratification on prognosis of patients with acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation].
Lu Y; Wu T; Zhao YL; Cao XY; Liu DY; Zhang JP; Xiong M; Zhou JR; Sun RJ; Wei ZJ; Wang H; Liu HX; Wang T; Tong CR; Ji SQ; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):44-49. PubMed ID: 28219225
[No Abstract] [Full Text] [Related]
32. Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.
Le Y; Fraineau S; Chandran P; Sabloff M; Brand M; Lavoie JR; Gagne R; Rosu-Myles M; Yauk CL; Richardson RB; Allan DS
Stem Cell Rev Rep; 2016 Apr; 12(2):235-44. PubMed ID: 26649729
[TBL] [Abstract][Full Text] [Related]
33. Treating acute myeloid leukemia in the modern era: A primer.
Blum WG; Mims AS
Cancer; 2020 Nov; 126(21):4668-4677. PubMed ID: 32767757
[TBL] [Abstract][Full Text] [Related]
34. Induction and postremission strategies in acute myeloid leukemia: state of the art and future directions.
Rosenblat TL; Jurcic JG
Hematol Oncol Clin North Am; 2011 Dec; 25(6):1189-213. PubMed ID: 22093583
[TBL] [Abstract][Full Text] [Related]
35. [AML treatment strategy based on cytogenetic abnormalities and somatic mutations].
Imai Y
Rinsho Ketsueki; 2015 Oct; 56(10):1932-41. PubMed ID: 26458431
[TBL] [Abstract][Full Text] [Related]
36. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
Starý J; Kobylka P; Sedlácek P; Komrska V; Vávra V; Syrůcková Z; Smísek P; Hrubá A; Korínková P; Matĕjková E; Cukrová V; Dolezalová L; Loudová M; Sejkorová J; Kvĕch J
Cas Lek Cesk; 1998 Jun; 137(12):363-7. PubMed ID: 9721472
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of haploidentical hematopoietic stem cell transplantation compared to HLA-matched transplantation for primary refractory acute myeloid leukemia.
Gu B; Zhang X; Chen G; Wu X; Ma X; Chen S; Wu D
Ann Hematol; 2018 Nov; 97(11):2185-2194. PubMed ID: 30039296
[TBL] [Abstract][Full Text] [Related]
38. Improved outcome of childhood acute myeloid leukemia in an Eastern European country: Lithuanian experience.
Kairiene I; Pasauliene R; Lipunova N; Vaitkeviciene G; Rageliene L; Rascon J
Eur J Pediatr; 2017 Oct; 176(10):1329-1337. PubMed ID: 28812191
[TBL] [Abstract][Full Text] [Related]
39. The rocky road to personalized medicine in acute myeloid leukaemia.
Brinda B; Khan I; Parkin B; Konig H
J Cell Mol Med; 2018 Mar; 22(3):1411-1427. PubMed ID: 29327808
[TBL] [Abstract][Full Text] [Related]
40. Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy.
Carter JL; Hege K; Yang J; Kalpage HA; Su Y; Edwards H; Hüttemann M; Taub JW; Ge Y
Signal Transduct Target Ther; 2020 Dec; 5(1):288. PubMed ID: 33335095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
